Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07534267 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Understanding MPXV Viral Clearance, Transmission Dynamics, and Mpox Vaccine Effectiveness in West Africa : Guinea

Study acronym: MOVIE-TRACE-WA
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study has three primary objectives to address the public health challenges of the Mpox outbreak in Guinea, West Africa. Objective 1 (MOVIE-West Africa) focuses on understanding the kinetics of Monkeypox virus (MPXV) elimination from the human body in Mpox cases. Objective 2 (TRACE-West Africa) aims to determine the MPXV transmission dynamics between Mpox cases and their contacts. Objective 3 (VE-West Africa) examines the vaccine effectiveness of the MVA-BN vaccine in protection against MPXV infection and Mpox disease.
Trial Details
NCT Number NCT07534267
Lead Sponsor London School of Hygiene and Tropical Medicine
Collaborators: University of Glasgow, Centre National de Formation et de Recherche en Sante Rurale, Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia, Agence Nationale de Sécurité Sanitaire de Guinée (ANSS), Institut National de la Santé Publique de Guinée (INSP)
Conditions
(from sponsor)		 Mpox (Monkeypox), Monkeypox
Related terms Mpox, Monkeypox
Enrollment 992 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov